Fact CheckerSign in

NCT06593405RecruitingEarly phase 1

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma

Source: ClinicalTrials.gov · Last updated 12 May 2026

Brief summary (registry, in English)

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are: Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task? Participants will: Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

Status (registry)
Recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
50 (estimated)
First submitted
26 Aug 2024
Start date
22 Apr 2025
Primary completion date
5 Dec 2026
Lead sponsor
MCPHS University
NCT number
NCT06593405

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 50
  • From 22 Apr 2025 to the primary completion date, 5 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Clients with other age related eye diseases other than AMD, DR or Glaucoma.

Other

  • Clients who do not wish to participate in this study.

Who the study is looking for

  • Clients with AMD, DR or Glaucoma
  • Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

Age in the registry: 50 years to 100 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MCPHS 10 Lincoln Square
Coordinator of this site? Confirm its status
WorcesterUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.